Trial Profile
Effects of aliskiren on cardiac sympathetic activity in patients with systolic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2012
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Heart failure therapies
- Indications Heart failure
- Focus Pharmacodynamics; Therapeutic Use
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 04 Dec 2011 New trial record
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.